1. Nimotuzumab plus induction chemotherapy followed by radiotherapy/concurrent chemoradiotherapy plus nimotuzumab for locally advanced nasopharyngeal carcinoma: protocol of a multicentre, open-label, single-arm, prospective phase II trial. Issue 8 (25th August 2022) Authors: Yuan, Jing-Jing; Ding, Jian-Wu; Li, Jin-Wei; Hu, Rong-Huan; Gong, Dan; Hu, Jia-Li; Zhu, Kai-Bin; Liu, Yan; Ding, Yu-Hai; Wei, Jia-Wang; Zeng, Jian-Lun; Lu, Zhi-Bing; Yin, Wei-Hua; Ai, Su-Fen; Zha, Guo-Hua; Zhang, Zhi-Lin; Zou, Rui; Zeng, Lei Journal: BMJ open Issue: Volume 12:Issue 8(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗